Migita, K <br/><br/>
FK506 augments glucocorticoid-mediated cyclooxygenase-2 down-regulation in human rheumatoid synovial fibroblasts.  [electronic resource] 

 -  Laboratory investigation; a journal of technical methods and pathology  Feb 2000 
 - 135-41 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0023-6837 
<br/><br/><label>Standard No.: </label>10.1038/labinvest.3780017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Arthritis, Rheumatoid--enzymology<br/>Base Sequence<br/>Cells, Cultured<br/>Cyclooxygenase 2<br/>DNA Primers<br/>Dexamethasone--pharmacology<br/>Down-Regulation--drug effects<br/>Fibroblasts--drug effects<br/>Fluorescent Antibody Technique, Indirect<br/>Humans<br/>Isoenzymes--genetics<br/>Membrane Proteins<br/>NF-kappa B--metabolism<br/>Promoter Regions, Genetic<br/>Prostaglandin-Endoperoxide Synthases--genetics<br/>RNA, Messenger--genetics<br/>Receptors, Glucocorticoid--metabolism<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Subcellular Fractions--metabolism<br/>Synovial Membrane--drug effects<br/>Tacrolimus--pharmacology<br/>Transcription, Genetic--drug effects